학술논문
Rituximab is effective for extensive steroid-refractory chronic graft-vs.-host-disease.
Document Type
Article
Source
Subject
*LETTERS to the editor
*GRAFT versus host disease
*
Language
ISSN
1042-8194
Abstract
A letter to the editor is presented concerning the effectiveness of rituximab for extensive steroid-refractory chronic graft-versus-host disease.